119 related articles for article (PubMed ID: 16646301)
1. [Pathogenesis of chronic obstructive pulmonary disease. Cellular mechanisms (part I)].
Mróz RM; Szulakowski P; Pierzchala W; Chyczewska E; MacNee W
Wiad Lek; 2006; 59(1-2):92-6. PubMed ID: 16646301
[TBL] [Abstract][Full Text] [Related]
2. Cytokines in chronic obstructive pulmonary disease.
Chung KF
Eur Respir J Suppl; 2001 Dec; 34():50s-59s. PubMed ID: 12392035
[TBL] [Abstract][Full Text] [Related]
3. Validation of the anti-inflammatory properties of small-molecule IkappaB Kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle.
Catley MC; Sukkar MB; Chung KF; Jaffee B; Liao SM; Coyle AJ; Haddad el-B; Barnes PJ; Newton R
Mol Pharmacol; 2006 Aug; 70(2):697-705. PubMed ID: 16687566
[TBL] [Abstract][Full Text] [Related]
4. Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview.
Di Stefano A; Caramori G; Ricciardolo FL; Capelli A; Adcock IM; Donner CF
Clin Exp Allergy; 2004 Aug; 34(8):1156-67. PubMed ID: 15298554
[TBL] [Abstract][Full Text] [Related]
5. Repression of inflammatory gene expression in human pulmonary epithelial cells by small-molecule IkappaB kinase inhibitors.
Newton R; Holden NS; Catley MC; Oyelusi W; Leigh R; Proud D; Barnes PJ
J Pharmacol Exp Ther; 2007 May; 321(2):734-42. PubMed ID: 17322026
[TBL] [Abstract][Full Text] [Related]
6. Chemotactic mediators of Th1 T-cell trafficking in smokers and COPD patients.
Brozyna S; Ahern J; Hodge G; Nairn J; Holmes M; Reynolds PN; Hodge S
COPD; 2009 Feb; 6(1):4-16. PubMed ID: 19229703
[TBL] [Abstract][Full Text] [Related]
7. Rhinovirus replication in human macrophages induces NF-kappaB-dependent tumor necrosis factor alpha production.
Laza-Stanca V; Stanciu LA; Message SD; Edwards MR; Gern JE; Johnston SL
J Virol; 2006 Aug; 80(16):8248-58. PubMed ID: 16873280
[TBL] [Abstract][Full Text] [Related]
8. Smoke, choline acetyltransferase, muscarinic receptors, and fibroblast proliferation in chronic obstructive pulmonary disease.
Profita M; Bonanno A; Siena L; Bruno A; Ferraro M; Montalbano AM; Albano GD; Riccobono L; Casarosa P; Pieper MP; Gjomarkaj M
J Pharmacol Exp Ther; 2009 May; 329(2):753-63. PubMed ID: 19190237
[TBL] [Abstract][Full Text] [Related]
9. [Pathogenesis of chronic obstructive pulmonary disease. Molecular mechanisms (part II)].
Szulakowski P; Mróz RM; Pierzchała W; Chyczewska E; MacNee W
Wiad Lek; 2006; 59(3-4):250-4. PubMed ID: 16813274
[TBL] [Abstract][Full Text] [Related]
10. Airway inflammation in chronic obstructive pulmonary disease.
Górska K; Maskey-Warzechowska M; Krenke R
Curr Opin Pulm Med; 2010 Mar; 16(2):89-96. PubMed ID: 19904205
[TBL] [Abstract][Full Text] [Related]
11. Insulin regulates cytokines and intercellular adhesion molecule-1 gene expression through nuclear factor-kappaB activation in LPS-induced acute lung injury in rats.
Martins JO; Zanoni FL; Martins DO; Coimbra R; Krieger JE; Jancar S; Sannomiya P
Shock; 2009 Apr; 31(4):404-9. PubMed ID: 18791499
[TBL] [Abstract][Full Text] [Related]
12. Chronic obstructive pulmonary disease and lung cancer: new molecular insights.
Adcock IM; Caramori G; Barnes PJ
Respiration; 2011; 81(4):265-84. PubMed ID: 21430413
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells.
Grund EM; Kagan D; Tran CA; Zeitvogel A; Starzinski-Powitz A; Nataraja S; Palmer SS
Mol Pharmacol; 2008 May; 73(5):1394-404. PubMed ID: 18252806
[TBL] [Abstract][Full Text] [Related]
14. Mediators of chronic obstructive pulmonary disease.
Barnes PJ
Pharmacol Rev; 2004 Dec; 56(4):515-48. PubMed ID: 15602009
[TBL] [Abstract][Full Text] [Related]
15. Intracellular JNK, p38 MAPK and NF-kappaB regulate IL-25 induced release of cytokines and chemokines from costimulated T helper lymphocytes.
Wong CK; Li PW; Lam CW
Immunol Lett; 2007 Oct; 112(2):82-91. PubMed ID: 17719653
[TBL] [Abstract][Full Text] [Related]
16. CCK-8 inhibits LPS-induced IL-1beta production in pulmonary interstitial macrophages by modulating PKA, p38, and NF-kappaB pathway.
Li S; Ni Z; Cong B; Gao W; Xu S; Wang C; Yao Y; Ma C; Ling Y
Shock; 2007 Jun; 27(6):678-86. PubMed ID: 17505309
[TBL] [Abstract][Full Text] [Related]
17. Thymulin and zinc (Zn2+)-mediated inhibition of endotoxin-induced production of proinflammatory cytokines and NF-kappaB nuclear translocation and activation in the alveolar epithelium: unraveling the molecular immunomodulatory, anti-inflammatory effect of thymulin/Zn2+ in vitro.
Haddad JJ
Mol Immunol; 2009 Dec; 47(2-3):205-14. PubMed ID: 19850345
[TBL] [Abstract][Full Text] [Related]
18. Cells, mediators and Toll-like receptors in COPD.
Sarir H; Henricks PA; van Houwelingen AH; Nijkamp FP; Folkerts G
Eur J Pharmacol; 2008 May; 585(2-3):346-53. PubMed ID: 18410916
[TBL] [Abstract][Full Text] [Related]
19. Halofuginone inhibits NF-kappaB and p38 MAPK in activated T cells.
Leiba M; Cahalon L; Shimoni A; Lider O; Zanin-Zhorov A; Hecht I; Sela U; Vlodavsky I; Nagler A
J Leukoc Biol; 2006 Aug; 80(2):399-406. PubMed ID: 16769768
[TBL] [Abstract][Full Text] [Related]
20. Influence of smoking cessation on airway T lymphocyte subsets in COPD.
Roos-Engstrand E; Ekstrand-Hammarström B; Pourazar J; Behndig AF; Bucht A; Blomberg A
COPD; 2009 Apr; 6(2):112-20. PubMed ID: 19378224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
